Nilsson E
Ann Clin Res. 1982 Aug;14(4):165-72.
Eighty three patients who were comatose or confused due to intoxication with various drugs were treated repeatedly with 2 mg doses of physostigmine until maximal neurological improvement or side effects appeared. During therapy special attention was paid to the level of consciousness (Glasgow coma score) and to the general cardiorespiratory state. According to the main drug ingested the patients were divided into the following groups: anticholinergic (35 patients), benzodiazepine (12 patients), non-anticholinergic (22 patients) and unclassified (14 patients). The best antidotal effect of physostigmine was in the anticholinergic group (91%) and in the benzodiazepine group (67%), whereas in the non-anticholinergic and in the unclassified group only 32% and 50% of the patients, respectively, showed any improvement in mental condition during the physostigmine application. After the antidotal therapy, relapses occurred in 21/32 patients in the anticholinergic group, whereas the figures for the benzodiazepine and the non-anticholinergic groups were only 2/8 and 0/7. Major side effects of physostigmine were noted in two patients, one had ventricular extrasystoles and the other an acute grand mal attack. In this series the diagnostic value of physostigmine was considerable, but the therapeutic benefit was limited.
83名因各种药物中毒而昏迷或意识模糊的患者,反复接受2毫克剂量的毒扁豆碱治疗,直至神经功能得到最大改善或出现副作用。治疗期间,特别关注意识水平(格拉斯哥昏迷评分)和总体心肺状态。根据主要摄入药物,患者被分为以下几组:抗胆碱能药物组(35例)、苯二氮䓬类药物组(12例)、非抗胆碱能药物组(22例)和未分类组(14例)。毒扁豆碱的最佳解毒效果出现在抗胆碱能药物组(91%)和苯二氮䓬类药物组(67%),而在非抗胆碱能药物组和未分类组中,分别只有32%和50%的患者在使用毒扁豆碱期间精神状态有所改善。解毒治疗后,抗胆碱能药物组32例患者中有21例复发,而苯二氮䓬类药物组和非抗胆碱能药物组的复发率分别仅为2/8和0/7。有两名患者出现了毒扁豆碱的主要副作用,一名出现室性早搏,另一名出现急性大发作。在这个系列中,毒扁豆碱的诊断价值相当大,但治疗益处有限。